Enhancer of zeste homolog 2 (EZH2) is a frequently upregulated epigenetic factor in human cancers, while deleted in liver cancer 1 (DLC1) is an anticancer gene that is often expressed at low levels or not expressed in many malignancies. The gene discussed is DLC1; the disease is cancer.